CTI BioPharma gets Israel's approval for sale of cancer drug By: Puget Sound Business Journal (Seattle) via Business Journals July 23, 2014 at 13:58 PM EDT CTI BioPharma Corp. has won approval from Israeli officials to distribute its Pixuvri drug for certain patients with cancer in Israel... Read More >> Related Stocks: CTI